Riskpilot← Back to searchSign inGet full accessBIOVANTAGE.DK ApS
APSBankruptCVR 36498544Skindergade 15Research and experimental development on natural sciences and engineering · NACE 7210Est. 20151 employees
Revenue 2023
DKK -244K
+159% vs 2022
EBITDA margin
100.0%
-171% vs 2022
Equity ratio
-84.6%
Financial strength
Net profit 2023
DKK -613K
-131% vs 2022
| Revenue | DKK -244K | +159% |
| EBITDA | DKK -244K | -171% |
| Net profit | DKK -613K | -131% |
| Total assets | DKK 6,9M | +1% |
| Equity | DKK -5,8M | -12% |
| Employees | 1 | — |
Legal name
BIOVANTAGE.DK ApS
CVR number
36498544
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
15. januar 2015
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Skindergade 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -281 | 2.686 | 2.991 | 2.664 | 3.277 | 4.092 | -94 | -244 |
| Staff expenses | -254 | -751 | -0 | -522 | -1.445 | -1.188 | -4 | -0 |
| EBITDA | -535 | 1.935 | 2.991 | 2.141 | 1.832 | 2.904 | -90 | -244 |
| Depreciation & amort. | -0 | -3.740 | -4.128 | -3.586 | -4.152 | -0 | -0 | -0 |
| EBIT | -535 | -1.806 | -1.137 | -1.445 | -2.320 | 2.904 | -90 | -244 |
| Net financials | -231 | -698 | -787 | -933 | 868 | -225 | -250 | -475 |
| Profit before tax | -767 | -2.504 | -1.924 | -2.378 | -1.452 | 2.679 | -340 | -719 |
| Tax | -169 | -551 | -423 | -515 | -315 | 591 | -75 | -106 |
| Net profit | -598 | -1.953 | -1.501 | -1.864 | -1.138 | 2.088 | -265 | -613 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 17.283 | 18.655 | 17.395 | 11.483 | 7.835 | 7.034 | 6.805 | 6.850 |
| Equity | -548 | -2.501 | -4.002 | -5.865 | -7.003 | -4.915 | -5.180 | -5.792 |
| Long-term debt | 5.275 | 6.205 | 6.992 | 7.879 | 10.721 | 11.411 | 11.840 | 12.498 |
| Short-term debt | 12.556 | 14.950 | 14.405 | 9.469 | 4.118 | 537 | 145 | 145 |
| Total debt | 17.831 | 21.155 | 21.396 | 17.348 | 14.838 | 11.948 | 11.985 | 12.643 |
EBITDA margin
-24362800.0%
This company
15.8%
Market median
-154195037% vs market
20162023
Equity ratio
-84.6%
This company
38.2%
Market median
-321% vs market
20162023
Return on equity
-61291600.0%
This company
18.4%
Market median
-333106622% vs market
20162023
Net profit margin
-61291600.0%
This company
8.1%
Market median
-756686520% vs market
20162023
Asset turnover
-0.04×
This company
1.12×
Market median
-104% vs market
20162023
Debt / equity
2.18×
This company
0.62×
Market median
-252% vs market
20162023
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-01-15 – 2016-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SK Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
OL Unofficial title | Unofficial title | 2024 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2015 | |
| Individual | 100.0% | 100.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOVANTAGE.DK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Kræmer | Chief Executive Officer | 0 companies |
| Ole Larsen | Unofficial title | 0 companies |